Advertisement
NBRV Novinky na Forexu
Nabriva Inks Exclusive Distribution Agreement With Er-Kim
Biopharmaceutical company Nabriva Therapeutics plc (NBRV) announced Monday that it has entered into an exclusive Distribution Agreement with Er-Kim, a leading partner for biotech companies in international markets, for the oral and intravenous formulations of XENLETA (lefamulin).
RTTNews
|
Před 1023 dny
